Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study-Reference-Cited by-同舟云学术

Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study

Published:1996-11 Issue:5 Volume:25 Page:591-598
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Dusheiko Geoffrey,Main Janice,Thomas Howard,Reichard Olle,Lee Christine,Dhillon Amar,Rassam Suhra,Fryden Aril,Reesink Henk,Bassendine Margaret,Norkrans Gunnar,Cuypers Theo,Lelie Nico,Telfer Paul,Watson Jon,Weegink Christine,Sillikens Peter,Weiland Ola

Publisher

Elsevier BV

Subject

Hepatology

Reference23 articles.

1. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma;Colombo;Lancet,1989

2. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis;Bruix;Lancet,1989

3. Long-term follow-up of acute and chronic non-A non-B hepatitis: evidence of progression to liver cirrhosis;Realdi;Gut,1982

4. Recombinant interferon alfa therapy for chronic hepatitis C;Di-Bisceglie;N Engl J Med,1989

5. Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa

Cited by 308 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Excessive Dynamic Airway Collapse After Entecavir Use in a Patient With Pegylated Interferon-Induced Undifferentiated Connective Tissue Disease and Entecavir Use to Prevent Hepatitis B Virus Reactivation Upon Giving Rituximab;Cureus;2024-06-21

2. The Overview of Potential Antiviral Bioactive Compounds in Poxviruses;Advances in Experimental Medicine and Biology;2024

3. Synthetic 1,2,4-triazole-3-carboxamides Induce Cell Cycle Arrest and Apoptosis in Leukemia Cells;Current Pharmaceutical Design;2023-12

4. Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis;Viruses;2023-09-29

5. Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C;World Journal of Gastroenterology;2023-02-14